INS and type 2 diabetes mellitus: In some of these studies, the improved glucose tolerance during or after exendin-4 treatment reflects marked improvement of deficient insulin secretion due to stimulation of β-cell regeneration [75] or up-regulation of β-cell function in T2DM patients [76].